Yes thats a distinct possibility. I'm assuming the market will respond favourably to a ROW announcement but it will be brief and the interest will dissipate.
The market will definitely take notice of positive NNZ-2591 results and re-rate the company accordingly imho. A hostile takeover could happen at any time even post-NNZ2591 results, but its going to be more expensive to do so post-NNZ2591trials I believe. I'm probably shortchanging the company here; if the NNZ-2591 disorders are worth 5 times the trofinetide market which might eventually be valued at $2 billion, then the raider will still make a packet if they bought Neuren for $3-4 billion. So it may well be that the raider waits for positive NNZ-2591 results before committing.
A languishing share price would be attractive to a raider, but I figure a buoyant share price isn't going to stop them either.
Share Price, page-3797
-
- There are more pages in this discussion • 8,274 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.11 |
Change
-0.165(1.08%) |
Mkt cap ! $1.930B | |||
| Open | High | Low | Value | Volume |
| $15.38 | $15.47 | $14.93 | $5.601M | 371.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 93 | $15.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.11 | 900 | 22 |
View Market Depth
| Last trade - 15.54pm 30/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |